The poster is entitled "Mobilization and Isolation of Human Very Small Embryonic-Like Stem Cells (VSELs) from Peripheral Blood". Authors of the abstract included:
Dr. Mariusz Ratajczak, M.D., Ph.D., Director of the Stem Cell Biology Program at University of Louisville, which partners with NeoStem to develop technologies, based on NeoStem's exclusive license, to identify and isolate rare adult stem cells called very small embryonic-like stem cells;
Dr. Wayne A. Marasco, M.D., Ph.D., Associate Professor at the Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School, and Chairman of NeoStem's Scientific Advisory Board;
Denis O. Rodgerson, Ph.D., MSC, Director of Stem Cell Science at NeoStem.
Satish Medicetty, Ph.D., formerly Director of Stem Cell Research & Laboratory Operations at NeoStem.
The abstract shows that very small embryonic-like stem cells, normally
rare in peripheral blood, can be released in greater numbers from the bone
marrow by using an FDA approved drug called G-CSF. They can then be collected
by a process called apheresis, a process used as standard-of-care in blood
donations. The authors postulate that G-CSF mobilization could become a novel
strategy to obtain human pluripotent stem cells, which are stem cells that
have the potential to regenerate all the cell types of the body. In this
poster, the authors have presented data taken from 28 human donors that
demonstrate the significant
|SOURCE NeoStem, Inc.|
Copyright©2010 PR Newswire.
All rights reserved